Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
1.866B
Cash
371.6M
Avg Qtr Burn
-49.58M
Short % of Float
11.61%
Insider Ownership
28.00%
Institutional Own.
61.77%
Qtr Updated
06/30/24
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Navacaprant (NMRA-140) Details Major depressive disorder, Mental health Big Mover™ Suspected Mover™ Susp. Mover™ | Phase 3 Data readout | |
Navacaprant (NMRA-140) Details Mental health, Bipolar depression | Phase 2 Data readout | |
NMRA-511 Details Agitation in Alzheimer's Disease, Alzheimer's disease | Phase 1b Data readout | |
NMRA-266 Details Mental health, Schizophrenia | Phase 1 Update |